MYCOD
Mydecine Innovations Group Inc - Ordinary Shares New

1,265
Mkt Cap
$118,100.00
Volume
24.00
52W High
$0.45
52W Low
$0.005
PE Ratio
0.07
MYCOD Fundamentals
Price
$0.0956
Prev Close
$0.2362
Open
$0.0956
50D MA
$0.1606
Beta
0.00
Avg. Volume
43.74
EPS (Annual)
-$1.93
P/B
-0.01
Loading...
Loading...
Mydecine Innovations Group, Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Mydecine Innovations Group Inc - Ordinary Shares New?
What is the 52-week high for Mydecine Innovations Group Inc - Ordinary Shares New?
What is the 52-week low for Mydecine Innovations Group Inc - Ordinary Shares New?
What is Mydecine Innovations Group Inc - Ordinary Shares New stock price today?
What was Mydecine Innovations Group Inc - Ordinary Shares New stock price yesterday?
What is the PE ratio of Mydecine Innovations Group Inc - Ordinary Shares New?
What is the Price-to-Book ratio of Mydecine Innovations Group Inc - Ordinary Shares New?
What is the 50-day moving average of Mydecine Innovations Group Inc - Ordinary Shares New?

Latest MYCOD News

View
No MYCOD news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.